Literature DB >> 402068

Chronic active hepatitis. Prolonged survival without treatment.

T O Lipman, L B Seeff, W O Dobbins.   

Abstract

A case is presented of a patient with established HBsAg-positive chronic active hepatitis and cirrhosis of at least 14 years duration. The disease, although untreated, has caused the patient relatively little disability. The implications of the patient's prolonged illness are discussed with reference to current knowledge of chronic active hepatitis. It is concluded that corticosteroid therapy may not be a mandatory requirement for all patients with this disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402068     DOI: 10.1007/bf01077397

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  22 in total

1.  Chronic hepatitis.

Authors:  A G Redeker
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

2.  Editorial: The fading menace of hepatitis.

Authors:  K S Henley; H D Appelman
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

3.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

4.  Cirrhosis of the liver associated with 1 -antitrypsin deficiency.

Authors:  K G Ishak; E H Jenis; M L Marshall; B H Bolton; G C Battistone
Journal:  Arch Pathol       Date:  1972-11

5.  Isoniazid hepatitis.

Authors:  W C Maddrey; J K Boitnott
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

6.  Methyldopa-induced submassive hepatic necrosis.

Authors:  O U Rehman; T A Keith; E A Gall
Journal:  JAMA       Date:  1973-06-04       Impact factor: 56.272

Review 7.  Active chronic hepatitis.

Authors:  S P Mistilis; C R Blackburn
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

8.  Chronic hepatitis as a first manifestation of Wilson's disease.

Authors:  I Sternlieb; I H Scheinberg
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

9.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Authors:  W H Summerskill; M G Korman; H V Ammon; A H Baggenstoss
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

10.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.